The sector has never looked at numbers like this. This dwarfs the INCY deal, and that boggled.......
Wednesday March 1, 7:05 am Eastern Time
Company Press Release
PE Corporation Announces Follow-On Public Stock
Offering of 3.8 Million Shares of Celera Genomics
Stock at $225 Per Share
ROCKVILLE, Md.--(BW HealthWire)--March 1, 2000--PE Corporation today announced the public offering of 3.8 million
shares of Celera Genomics common stock at a price of $225.00 per share. The underwriters also have an option to purchase
up to an additional 570,000 shares of Celera Genomics common stock to cover over-allotments. The net proceeds to Celera
as a result of the offering, after fees and expenses, are expected to be $820 million.
The shares, all of which were sold by Celera Genomics, were offered by an underwriting group for which Morgan Stanley
Dean Witter, Goldman, Sachs & Co., SG Cowen, ING Barings, and Bear Stearns & Co., Inc. are acting as representatives.
The net proceeds from the offering are intended primarily to fund Celera's new product and technology development activities
in functional genomics, with an emphasis on proteomics and personalized health/medicine. Celera also intends to use the net
proceeds for general corporate purposes, including possible acquisitions, alliances, or collaborations. (snip) |
